Tuesday February 9 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

HERCEPTIN Pages on BioPortfolio:

Biotechnology News HERCEPTIN Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/HERCEPTIN-news.htm...

BioPortfolio - Herceptin
Herceptin - BioPortfolio - Indepth. ... Companies working in the area of Herceptin from Bioportfolio's Biocorporate database : BioPortfolio Logo ...
http://www.bioportfolio.com/indepth/Herceptin.html...

BioPortfolio's Stomach News and Headlines
Herceptin Now Approved In The EU For Patients With HER2-positive ... Roche gets EU approval for Herceptin to treat HER2-positive advanced stomach cancer ...
http://www.bioportfolio.co.uk/Health_News/Stomach.shtml...

BioPortfolio - Clinical subjects - Biotechnology, Pharmaceutical ...
Herceptin Fab (antibody) - light and heavy chains. Trastuzumab (Herceptin) is a monoclonal antibody that interferes with the HER2/neu receptor. ...
http://www.bioportfolio.com/biocorporate/clinical-subjects.p...

BioPortfolio Biotechnology BioNews : live article
"Building upon the foundation laid by Rituxan, Herceptin, Avastin and Tarceva, we hope that these new investigational molecules may one day become part of ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

Antibody Therapeutics - Product Development, Market Trends, and ...
The worldwide half yearly sales of Herceptin(R) during the first half of 2006 ... Further growth in the Herceptin(R) market is predicted and the annual peak
...
http://www.bioportfolio.com/cgi-bin/acatalog/Antibody_Therap...

Biotechnology News PARAPLATIN Search
Combination of Herceptin with Nonanthracycline-based Chemotherapy Appears to ... Herceptin provides a benefit in combination with either anthracycline- or. ...
http://www.bioportfolio.co.uk/PARAPLATIN-news.htm...

BioPortfolio - Halozyme Therapeutics - Profile
Roche: novel Herceptin formulation promises greater convenience. Pharmacy Choice : Jan 22 2010 11:22PM Matching: halozyme therapeutics ...
http://www.bioportfolio.com/biocorporate/23804-Halozyme%2BTh...

BioPortfolio.com - BioWeb OMNITROPE SOMATROPIN RECOMBINANT isrupt ...
Home Contact Us Site Index Search [ Products -- Nutropin ] Products Home ONCOLOGY Avastin Herceptin Rituxan Tarceva IMMUNOLOGY Raptiva Xolair VASCULAR
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

BioPortfolio Limited Impact of Pharmacogenomics on Public ...
Figure 3.24: Genentech – development history of Herceptin/HercepTest 80 ... Table 2.4: Patient stratification for Herceptin trials 37 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_1063.html...

Results from other life science and pharmaceutical sites:

Trastuzumab - Wikipedia, the free encyclopedia
Trastuzumab (INN; trade name Herceptin) is a monoclonal antibody that ..... Her- 2: the making of Herceptin, a revolutionary treatment for breast cancer. ...
http://en.wikipedia.org/wiki/Trastuzumab...

Genentech: Medicines: Herceptin
Herceptin is the approved antibody for the treatment of metastatic breast cancer for patients whose tumors overexpress the HER2 protein and who have not ...
http://www.gene.com/gene/products/information/oncology/herce...

Herceptin Again Proves Mettle Against Breast Cancer: MedlinePlus
29 Jan 2010 ... "The reason why Herceptin is so valuable to patients who have locally ... The new study, one of the largest looking at Herceptin in this ...
http://www.nlm.nih.gov/medlineplus/news/fullstory_94669.html...

Genentech: Medicines: Herceptin Development Timeline
Full prescribing information for Herceptin® (Trastuzumab)
http://www.gene.com/gene/products/information/oncology/herce...

Roche - Herceptin now approved in the EU for patients with HER2 ...
28 Jan 2010 ... The approval is based on the impressive results from the international ToGA trial, which showed that treatment with Herceptin significantly ...
http://www.roche.com/media/media_releases/med-cor-2010-01-28...

Genentech: Investors: Herceptin - Historical Sales
Skip to Content for Herceptin - Historical Sales Menu for Herceptin - Historical Sales About Us Menu Research Menu Development Menu Medicines Menu Investors ...
http://www.gene.com/gene/ir/financials/historical/herceptin....

Roche - Herceptin proven to benefit women with HER2 positive early ...
11 Mar 2009 ... The patients were treated for one year with Herceptin and followed up for four years. These data from the HERA study were presented at the ...
http://www.roche.com/media/media_releases/med-cor-2009-03-11...

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not ...
Herceptin safely and effectively. See full prescribing information for ... Herceptin is a HER2/neu receptor antagonist indicated for the treatment of ...
http://www.gene.com/gene/products/information/pdf/herceptin-...

Herceptin (R) Combined With Chemotherapy Improves Disease-Free ...
25 Apr 2005 ... Herceptin® Combined With Chemotherapy Improves Disease–Free Survival for Patients With Early–Stage Breast Cancer ...
http://www.nih.gov/news/pr/apr2005/nci-25.htm...

Herceptin-induced inhibition of phosphatidylinositol-3 kinase and ...
Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.
...
http://www.ncbi.nlm.nih.gov/pubmed/12124352...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2010 - BioPortfolio Limited.